Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP252915.RAEyL-yY2twOP-pm7RXvaAu3JMypOHUWCG2z3KwmF_JNM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP252915.RAEyL-yY2twOP-pm7RXvaAu3JMypOHUWCG2z3KwmF_JNM130_assertion type Assertion NP252915.RAEyL-yY2twOP-pm7RXvaAu3JMypOHUWCG2z3KwmF_JNM130_head.
- NP252915.RAEyL-yY2twOP-pm7RXvaAu3JMypOHUWCG2z3KwmF_JNM130_assertion description "[ASC amino-acid transporter 2 was expressed in 66% of patients, and was closely correlated with disease stage, lymphatic permeation, vascular invasion, CD98, cell proliferation, angiogenesis, and mTOR phosphorylation, particularly in patients with adenocarcinoma (AC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP252915.RAEyL-yY2twOP-pm7RXvaAu3JMypOHUWCG2z3KwmF_JNM130_provenance.
- NP252915.RAEyL-yY2twOP-pm7RXvaAu3JMypOHUWCG2z3KwmF_JNM130_assertion evidence source_evidence_literature NP252915.RAEyL-yY2twOP-pm7RXvaAu3JMypOHUWCG2z3KwmF_JNM130_provenance.
- NP252915.RAEyL-yY2twOP-pm7RXvaAu3JMypOHUWCG2z3KwmF_JNM130_assertion SIO_000772 24603303 NP252915.RAEyL-yY2twOP-pm7RXvaAu3JMypOHUWCG2z3KwmF_JNM130_provenance.
- NP252915.RAEyL-yY2twOP-pm7RXvaAu3JMypOHUWCG2z3KwmF_JNM130_assertion wasDerivedFrom befree-20150227 NP252915.RAEyL-yY2twOP-pm7RXvaAu3JMypOHUWCG2z3KwmF_JNM130_provenance.
- NP252915.RAEyL-yY2twOP-pm7RXvaAu3JMypOHUWCG2z3KwmF_JNM130_assertion wasGeneratedBy ECO_0000203 NP252915.RAEyL-yY2twOP-pm7RXvaAu3JMypOHUWCG2z3KwmF_JNM130_provenance.